After a frenetic first couple of weeks as far as big rounds go, this week was quieter than a library. Only one round of more than $100 million was reported — although it was actually $1 billion — as everything came to a crawl.
Health, Wellness & Biotech
While last year wasn’t the cascade of M&A activity many had wished for (and certainly the IPO pipeline never unfroze), it did provide some hope. Deal...
Thus far 2025 has come roaring in as far as large rounds go. Last week more than a dozen companies raised $100 million or more. This week there are...
Colossal Biosciences, a de-extinction startup looking at ways to bring back the dodo bird and the woolly mammoth, raised a $200 million Series C at a...
Healthcare startups using artificial intelligence have come out of the gate hot in the new year when it comes to fundraising.
Funding to Europe-based startups settled year over year in 2024. Funding reached $51 billion, down by 5% year over year from $54 billion invested in...
It certainly was a big week — with companies having to raise more than $100 million to make the list. Biotech- and healthcare-related startups led...
In this guest commentary, Caleb Appleton, a principal at Bison Ventures, offers up a framework biotech founders can use to determine whether they...
Private equity giant Blackstone Group is making a $300 million strategic investment into DDN, valuing the Chatsworth, California-based data storage...
As AI becomes more embedded in business operations, it is poised to fundamentally reshape company structures, especially in how products and services...
Although 2024 was an exceptionally lackluster year for new public offerings, the IPO market could gain momentum in 2025. In that vein, the Crunchbase...
67.1K Followers